Clinical Trial Update: A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating everolimus for neurocognitive problems in tuberous sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Cardiff University | Conditions: Tuberous Sclerosis | Phase 2 | Status: UNKNOWN